New cell implant aims to curb severe low blood sugar in type 1 diabetes
Disease control
Terminated
This study tested a new treatment called SR-02, which involves implanting insulin-producing cells into the abdomen of adults with type 1 diabetes who experience dangerously low blood sugar. Participants would need to take lifelong anti-rejection drugs to prevent the body from att…
Phase: PHASE1, PHASE2 • Sponsor: Seraxis • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC